The Road Ahead for the Canine Arthritis Treatment Market: Key Growth Trends and Opportunities to Watch
Updated 2025 Market Reports Released: Trends, Forecasts to 2034 – Early Purchase Your Competitive Edge Today!
What CAGR is Anticipated for the Canine Arthritis Treatment Market During the Forecast Period, and Why?
Significant growth has been witnessed in the canine arthritis treatment market in the past few years. The market size is set to increase from $2.35 billion in 2024 to $2.48 billion in 2025, indicating a compound annual growth rate (CAGR) of 5.6%. The growth experienced in the historic period can be tied back to factors such as the rising age of the pet population, enhanced awareness among pet owners, a concentrated emphasis on preventive care, growing disposable income and a surge in expenditure on veterinary care.
Expectations are certainly high for the canine arthritis treatment market to experience considerable expansion in the coming years. It’s projected that by 2029 the market will achieve a value of $3.06 billion, fueled by a compound annual growth rate (CAGR) of 5.4%. This growth during the forecast period is believed to be sparked by factors such as enhanced pet insurance offerings, a rise in arthritis cases, an increase in pet ownership, the escalating demand for less invasive surgery, and a higher incidence of arthritis in dogs. Also forming part of the forecast period’s trends are the innovations in treatment, advancements in the field of veterinary medicine, increased demand for advanced therapies, incorporation of technology, and groundbreaking technologies.
Which Primary Drivers Are Supporting the Continued Expansion of the Canine Arthritis Treatment Market?
The upsurge in pet ownership is anticipated to spur the expansion of the canine arthritis treatment market. This surge in pet ownership is due to individuals or households assuming responsibility for the needs, well-being, and companionship of domestic animals, which are primarily kept for enjoyment rather than service. Factors such as changes in lifestyle, the humanization of pets, and an increase in disposable incomes contribute to the rise in pet ownership rates. To manage and relieve their dogs’ arthritis symptoms, pet owners employ canine arthritis treatments, thereby enhancing their pets’ living standards and mobility. For example, data from the American Pet Products Association revealed that in October 2023, pet ownership was prevalent among 86.9 million US households, marking a 66% increase from 2022 numbers. Hence, the canine arthritis treatment market’s growth is being fuelled by the escalating rate of pet ownership.
Request Your Free Canine Arthritis Treatment Market Report Sample Now!
https://www.thebusinessresearchcompany.com/sample.aspx?id=16007&type=smp
Which Companies Are Poised to Shape the Future of the Canine Arthritis Treatment Market?
Major companies operating in the canine arthritis treatment market are:
• Merck & Co. Inc._x000D_
• Bayer AG_x000D_
• Eli Lilly and Company_x000D_
• Zoetis Inc._x000D_
• Boehringer Ingelheim Animal Health_x000D_
What Are the Latest Innovations and Trends Influencing the Canine Arthritis Treatment Market?
Leading firms in the canine arthritis treatment market are creating innovative remedies such as bedinvetmab injections, to tackle issues related to dog joint health and mobility. Bedinvetmab is an injection of monoclonal antibodies that functions by identifying and neutralizing nerve growth factor (NGF), a protein contributing to pain and used in veterinary medicine. For example, Zoetis Inc., an American animal health corporation, in May 2023, secured approval from the Food and Drug Administration (FDA) for Librela, a bedinvetmab injection. It is the first monoclonal antibody (mAb) approved by the FDA for use in dogs, and it works by attaching to and restraining the biological activity of canine nerve growth factor (NGF), which plays a role in managing pain linked with OA. Administered via subcutaneous injection once a month, it provides a convenient, long-term solution for managing canine OA-related pain.
Pre-order Your Report for Quick and Easy Delivery!
https://www.thebusinessresearchcompany.com/report/canine-arthritis-treatment-global-market-report
What Are the Strategic Segments Comprising the Canine Arthritis Treatment Market and Their Growth Contributions?
The canine arthritis treatment market covered in this report is segmented –
1) By Treatment Type: Drugs, Supplements, Surgical Procedures, Other Treatment Types
2) By Route Of Administration: Oral, Parenteral, Other Routes Of Administrations
3) By Arthritis Type: Osteoarthritis, Rheumatoid Arthritis, Osteochondrosis, Traumatic Arthritis
4) By Distribution Channels: Veterinary Clinics And Hospitals, Retail Pharmacies, Online Pharmacies
Subsegments:
1) By Drugs: Non-Steroidal Anti-Inflammatory Drugs (NSAIDs), Disease-Modifying Osteoarthritis Drugs (DMOADs), Corticosteroids, Analgesics And Pain Relievers
2) By Supplements: Glucosamine And Chondroitin Supplements, Omega-3 Fatty Acids And Fish Oil, Hyaluronic Acid Supplements, MSM (Methylsulfonylmethane) Supplements, Collagen-Based Supplements
3) By Surgical Procedures: Joint Replacement Surgery, Arthroscopy, Osteotomy, Synovectomy
4) By Other Treatment Types: Physical Therapy, Stem Cell Therapy, Platelet-Rich Plasma (PRP) Therapy, Cold Laser Therapy (Low-Level Laser Therapy), Acupuncture
What Regions Are Contributing Significantly to the Growth of the Canine Arthritis Treatment Market?
North America was the largest region in the canine arthritis treatment market in 2024. Asia-Pacifica is expected to be the fastest-growing region in the forecast period. The regions covered in the canine arthritis treatment market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
How Is the Scope and Reach of the Canine Arthritis Treatment Market Defined?
Canine arthritis treatment refers to the medical and therapeutic approaches for canine arthritis disease, a chronic condition characterized by inflammation and progressive deterioration of the cartilage within a dog’s joints. It is used to reduce pain and inflammation, maintain joint function, and slow the progression of the disease in dogs.
Browse Through More Similar Reports By The Business Research Company:
Gastrointestinal Bleeding Treatment Devices Global Market Report 2024
Psoriatic Arthritis Treatment Global Market Report 2024
Point-of-Use Water Treatment Systems Global Market Report 2024
About The Business Research Company:
With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.
Contact us at:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 3156230293
Asia +44 2071930708
Europe +44 2071930708
Email us at [email protected]
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
Found this article helpful? Share it on:
